These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 23535090

  • 21. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
    Asero R.
    Clin Exp Allergy; 2005 Jun; 35(6):713-6. PubMed ID: 15969659
    [Abstract] [Full Text] [Related]

  • 22. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.
    Colanardi MC, Nettis E, Traetta P, Daprile C, Fitto C, Aloia AM, Di Leo E, Ferrannini A, Vacca A.
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):82-5. PubMed ID: 18254487
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
    Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ.
    J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
    [Abstract] [Full Text] [Related]

  • 25. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
    Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F.
    Am J Clin Dermatol; 2002 May; 3(9):599-607. PubMed ID: 12444802
    [Abstract] [Full Text] [Related]

  • 26. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
    Inomata N, Osuna H, Yamaguchi J, Onoda M, Takeshita Y, Chiba Y, Kambara T, Ikezawa Z.
    J Dermatol; 2007 Mar; 34(3):172-7. PubMed ID: 17291297
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
    Trombetta D, Imbesi S, Vita G, Isola S, Minciullo PL, Saija A, Gangemi S.
    Arzneimittelforschung; 2009 Mar; 59(8):410-4. PubMed ID: 19813464
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
    Saff RR, Banerji A.
    Allergy Asthma Proc; 2015 Mar; 36(1):34-9. PubMed ID: 25562554
    [Abstract] [Full Text] [Related]

  • 31. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review.
    Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Cortellini G, Nizankowska-Mogilnicka E, Quaratino D, Romano A, Sanchez-Borges M, Torres-Jaen MJ.
    Int Arch Allergy Immunol; 2013 Mar; 160(2):126-33. PubMed ID: 23018315
    [Abstract] [Full Text] [Related]

  • 32. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G, Salzillo A, Piccolo A, Senna G, Piscitelli E, D'Amato M, D'Amato G.
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [Abstract] [Full Text] [Related]

  • 33. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S, Celik G, Ediger D, Mungan D, Demirel YS, Misirligil Z.
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [Abstract] [Full Text] [Related]

  • 34. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
    Muratore L, Ventura M, Calogiuri G, Calcagnile F, Quarta E, Muratore M, Ferrannini A.
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
    [Abstract] [Full Text] [Related]

  • 35. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
    Doña I, Barrionuevo E, Salas M, Cornejo-García JA, Perkins JR, Bogas G, Prieto A, Torres MJ.
    Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
    [Abstract] [Full Text] [Related]

  • 36. [Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan].
    Moriya M, Aihara M, Hirota R, Hirata Y, Ikinaga N, Takamura N, Kunimi Y, Uchida T, Ikezawa Z.
    Arerugi; 2011 Jun; 60(6):699-707. PubMed ID: 21709437
    [Abstract] [Full Text] [Related]

  • 37. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P, Ayuso P, Salas M, Plaza MC, Cornejo-García JA, Doña I, Torres MJ, Blanca-López N, Canto G, Guéant JL, Sanak M, Blanca M.
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [Abstract] [Full Text] [Related]

  • 38. Clinical Control of CSU with Antihistamines Allows for Tolerance of NSAID-Exacerbated Cutaneous Disease.
    Sánchez J, Diez S, Cardona R.
    J Allergy Clin Immunol Pract; 2020 Aug; 8(10):3577-3583.e1. PubMed ID: 32673879
    [Abstract] [Full Text] [Related]

  • 39. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE, Erkekol FÖ, Aydın Ö, Demirel YS, Mısırlıgil Z.
    Allergol Immunopathol (Madr); 2013 Aug; 41(3):181-8. PubMed ID: 23031659
    [Abstract] [Full Text] [Related]

  • 40. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
    Pérez-Alzate D, Cornejo-García JA, Pérez-Sánchez N, Andreu I, García-Moral A, Agúndez JA, Bartra J, Doña I, Torres MJ, Blanca M, Blanca-López N, Canto G.
    J Investig Allergol Clin Immunol; 2017 Aug; 27(1):32-39. PubMed ID: 28211343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.